Ameritas Investment Partners’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.2K | Buy |
5,091
+1,045
| +26% | +$15.6K | ﹤0.01% | 1920 |
|
|
2025
Q1 | $65.3K | Buy |
4,046
+654
| +19% | +$10.6K | ﹤0.01% | 1959 |
|
|
2024
Q4 | $79K | Hold |
3,392
| – | – | ﹤0.01% | 1920 |
|
|
2024
Q3 | $99.8K | Hold |
3,392
| – | – | ﹤0.01% | 1781 |
|
|
2024
Q2 | $79.7K | Buy |
+3,392
| New | +$79.7K | ﹤0.01% | 1872 |
|
|
2022
Q2 | – | Sell |
-148
| Closed | -$9K | – | 3227 |
|
|
2022
Q1 | $9K | Hold |
148
| – | – | ﹤0.01% | 2836 |
|
|
2021
Q4 | $18K | Hold |
148
| – | – | ﹤0.01% | 2695 |
|
|
2021
Q3 | $29K | Hold |
148
| – | – | ﹤0.01% | 2498 |
|
|
2021
Q2 | $26K | Hold |
148
| – | – | ﹤0.01% | 2599 |
|
|
2021
Q1 | $29K | Hold |
148
| – | – | ﹤0.01% | 2396 |
|
|
2020
Q4 | $29K | Hold |
148
| – | – | ﹤0.01% | 2296 |
|
|
2020
Q3 | $26K | Hold |
148
| – | – | ﹤0.01% | 2245 |
|
|
2020
Q2 | $34K | Buy |
148
+54
| +57% | +$12.4K | ﹤0.01% | 2070 |
|
|
2020
Q1 | $11K | Buy |
94
+39
| +71% | +$4.56K | ﹤0.01% | 2512 |
|
|
2019
Q4 | $11K | Hold |
55
| – | – | ﹤0.01% | 2703 |
|
|
2019
Q3 | $11K | Hold |
55
| – | – | ﹤0.01% | 2709 |
|
|
2019
Q2 | $9K | Hold |
55
| – | – | ﹤0.01% | 2835 |
|
|
2019
Q1 | $11K | Hold |
55
| – | – | ﹤0.01% | 2670 |
|
|
2018
Q4 | $10K | Hold |
55
| – | – | ﹤0.01% | 2674 |
|
|
2018
Q3 | $13K | Hold |
55
| – | – | ﹤0.01% | 2738 |
|
|
2018
Q2 | $15K | Buy |
+55
| New | +$15K | ﹤0.01% | 2669 |
|